The Current Mature Commercial Medicines Co Investment Strategy Analysis Of Risk Control

At present,chinese pharmaceutical circulation field has been changed greatly. Various mergers and acquisitions, restructuring activities has happened. The national medicine policy adjustment enterprise of pharmaceutical is connected with the business compnies’s strategy also made corresponding adjustments, integration of industry chain has brought new opportunities for investment.In the existing commercial pharmaceutical field business competitions is very fierce which was in logistics,third part logistics,medicine chain and traditional chinese medicine store, raw material medicine and preparation, medical equipment and other business module. The increasingly fierce competition, different enterprise choose different coping strategies. While investors positive or negative interpretation of policy, market planning and precision marketing has brought new opportunities for investors.Financing,capital operation and financial management are focusing on the cash flow,it’s a step of enterprise macro strategy,its relationship to the quality of operation quality. Under the guidance of macroscopic strategy in industry we must attach great importance to risk, medicine co’s investment risk preference, risk measurement establishes the prediction and measurement and risk paramenter system make the risk can be predicted be able to control. Measure can respond to and take effective measures Objectively, which effectively reduces the risk and enhance the controllability of the investment rate of return and risk.from the traditional investment theory, does expound the classification of industry investment behavior and the general theory and characteristics in this article. From the micro and macro economics angle, and the point of specification for business competition. described the investment opportunities in the new situation can be grasped. From the angle of enterprise growth cycle theory, expounds the necessity of investment direction of pharmaceutical related business reality adjustment; combined with years of business of KMC company practice, analysis of the current industry investment behavior rationality and risks arising from the scene, and sums up some effective means and decision making. Through the analysis of methods and tools to use the general nature of the investment decision-making, puts forward the pharmaceutical industry investment decision methods practical and effective tool.Finally, from a method logical point of view, we can draw the investment decision of reasonable general conclusions, and suitable for mature commercial Medicines Co general investment strategies and risk control methods.